查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715289

适体市场按类型、技术、形式、目标、应用和最终用户划分－2025-2030 年全球预测

Aptamers Market by Type, Technology, Form, Target, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计适体市场规模在 2024 年将达到 2.4998 亿美元，2025 年将达到 2.8051 亿美元，到 2030 年将达到 5.0391 亿美元，复合年增长率为 12.39%。

主要市场统计数据
基准年2024年 2.4998亿美元
预计年份：2025年 2.8051亿美元
预测年份 2030 5.0391亿美元
复合年增长率（%） 12.39%

适体正迅速从实验工具转变为各种科学技术应用中的关键组件。适体的演化正在透过提供高亲和性和特异性的目标结合重新定义诊断、治疗和环境监测等领域。最近的趋势包括整合尖端技术，加速适体的应用，并重新激发人们对其研究和开发的兴趣。各行各业的公司都在利用这些创新来增强侦测能力并改善治疗效果。该框架的扩展凸显了科学界开发更有效、更有针对性的解决方案的动力。随着市场不断成熟，适体正成为传统抗体和其他结合分子的强大竞争对手。在突破性创新和策略研究投资的推动下，适体市场正在经历一场转型，这不仅将增强现有流程，而且还将为精准医疗和个人化诊断的新途径铺平道路。这项叙述为更广泛地探索趋势、细分洞察以及塑造动态市场格局的关键驱动因素奠定了基础。

改变适体市场

适体市场正在发生深刻的变化，重新定义竞争框架和技术应用。新的科学突破和最尖端科技的引入正在改变长期存在的模式，推动产业向更高的效率和更广泛的市场延伸。最近在研发方面的大量投资加速了新适体序列及其相关功能的发现。这些转变不仅改变了目标的检测方式，也为创新的诊断平台和治疗解决方案铺平了道路。学术界和生物技术公司之间新兴的伙伴关係正在促进跨职能专业知识和更全面的应对市场挑战的方法，进一步推动这一转变。此外，策略联盟使公司能够简化生产流程并利用协同效应来降低生产成本。随着市场不断发展，相关人员越来越多地转向敏捷的产品开发模式，并采用能够实现即时数据监控和预测分析的数位转型策略。这种快速发展反映了生命科学领域更广泛的趋势，该领域正经历一个变革时代，其特征是前所未有的成长潜力和业务效率，传统界限不断被重新划定。

适体市场的关键细分洞察

对市场区隔的全面分析为了解适体市场的多样性提供了宝贵的见解。考虑按类型细分，市场研究涵盖核酸适体和胜肽适体。深入研究，核酸适体进一步分为 DNA 和 RNA 适体，突显了针对特异性和稳定性的细微方法。市场技术区隔同样重要，Cell-SELEX 技术和 LOPAC 1280 技术等先进方法推动着各种应用的创新。基于形式的细分区分液体和固体配方，并列出不同环境中不同的操作和应用特定优势。此外，基于主题的细分透过检查细胞、蛋白质、小分子和病毒突显了市场的广度。细胞分析进一步细分为癌细胞和健康细胞，以适应不同的研究和临床要求。基于应用的细分揭示了适体在多个领域的多样化用途，例如生物感测器、诊断、环境监测、研究和开发以及治疗。本部分进一步将生物感测器细分为电化学生物感测器和光学生物感测器，后者又分为光纤和基于萤光的替代品，以适应感测器性能标准的多样化。诊断方法分为血液诊断法、酵素连结方法、表面电浆共振方法等，环境监测则分为污染物检测及水质检测两大类。研发细分突显了生物标记发现和蛋白质相互作用等关键部分。另一方面，治疗领域的特点是专注于癌症治疗、心血管疾病和神经退化性疾病，其中癌症治疗本身则根据乳癌、大肠直肠癌和肺癌等特定疾病进行分析。最后，按最终用户细分包括学术和研究机构、生技公司、医院诊所和製药公司。这种分层细分框架不仅突显了适体的多样化应用和技术细节，而且还展示了市场满足不断变化的工业需求的弹性和适应性。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病盛行率上升推动对创新诊断解决方案的需求
      • 个人化医疗对精准标靶和治疗的需求日益增长
      • 拓展适体在各领域的应用
    • 限制因素
      • 生产成本高且可扩展性问题
    • 机会
      • 先进平台的开发及其与奈米技术的结合
      • 基于适体的生物感测器平台的建构及其在环境污染物即时监测中的应用
    • 任务
      • 与现有技术的竞争
  • 市场区隔分析
    • 类型：RNA适体的高特异性增加了其在治疗应用中的采用率
    • 应用：扩大适体在治疗各种疾病的应用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 适体市场依类型

  • 介绍
  • 核酸适体
    • DNA适体
    • RNA适体
  • 胜肽适体

第七章 适体市场：依技术分类

  • 介绍
  • 细胞SELEX技术
  • LOPAC 1280技术

第 8 章 适体市场：依形式

  • 介绍
  • 液体
  • 固体的

第九章 适体市场（依目标）

  • 介绍
  • 细胞
    • 癌细胞
    • 健康细胞
  • 蛋白质
  • 小分子
  • 病毒

第 10 章 适体市场：依应用

  • 介绍
  • 生物感测器
    • 电化学生物感测器
    • 光学生物感测器
      • 光纤
      • 萤光底座
  • 诊断
    • 血液学诊断
    • 酵素连结法
    • 表面等离子体共振
  • 环境监测
    • 污染物检测
    • 水质检测
  • 研究与开发
    • 生物标记发现
    • 蛋白质相互作用
  • 治疗
    • 癌症治疗
      • 乳癌
      • 大肠直肠癌
      • 肺癌
    • 心血管疾病
    • 神经退化性疾病

第 11 章 适体市场（依最终用户划分）

  • 介绍
  • 学术研究所
  • 生技公司
  • 医院和诊所
  • 製药公司

第 12 章：美洲适体市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太适体市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲适体市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 2bind GmbH
  • Agilent Technologies, Inc.
  • Aptagen, LLC
  • Aptamer Group
  • Aptamer Sciences, Inc.
  • AptaTargets SL
  • Aptus BIoTech SL
  • ATDBio Ltd.
  • Base Pair BIoTechnologies, Inc.
  • Basking Biosciences
  • Cage Bio, Inc.
  • Creative Biogene
  • Drive Therapeutics, LLC
  • Kaneka Corporation
  • Maravai LifeSciences
  • Mediomics, LLC
  • NeoVentures BIoTechnology, Inc.
  • NOVAPTECH
  • Novartis AG
  • Qualigen, Inc.
  • Raptamer Discovery Group, LLC
  • SomaLogic, Inc.
  • TAGCyx BIoTechnologies Inc.
  • Vivonics, Inc.
Product Code: MRR-4358BACA838E

The Aptamers Market was valued at USD 249.98 million in 2024 and is projected to grow to USD 280.51 million in 2025, with a CAGR of 12.39%, reaching USD 503.91 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 249.98 million
Estimated Year [2025] USD 280.51 million
Forecast Year [2030] USD 503.91 million
CAGR (%) 12.39%

Aptamers have rapidly moved from being an experimental tool to becoming a critical component in various scientific and technological applications. The evolution of aptamers is redefining sectors such as diagnostics, therapeutics, and environmental monitoring by providing high affinity and specificity in binding targets. In recent years, the integration of advanced technologies has accelerated their adoption, sparking renewed interest in research and development. Companies across the industry are capitalizing on these innovations to enhance detection capabilities and improve treatment outcomes. This expanding framework underscores the scientific community's drive to develop more effective and targeted solutions. As the market continues to mature, aptamers are emerging as a formidable competitor to traditional antibodies and other binding molecules. With breakthrough innovations and strategic research investments, the aptamers market is witnessing a transformation that not only augments existing processes but also opens new avenues for precision medicine and personalized diagnostics. This narrative sets the stage for a broader exploration of the trends, segmentation insights, and key drivers that are shaping a dynamic market landscape.

Transformative Shifts in the Aptamers Market Landscape

The aptamers market is undergoing profound changes that are redefining its competitive framework and technological applications. The infusion of novel scientific breakthroughs and cutting-edge technology has shifted longstanding paradigms, driving the industry toward greater efficiency and enhanced market reach. Recently, substantial investments in research and development have accelerated the discovery of new aptamer sequences and their associated functionalities. These shifts are not only altering the method of target detection but are also paving the way for innovative diagnostic platforms and therapy solutions. Emerging partnerships between academic entities and biotech companies have further fueled this transition, promoting cross-functional expertise and a more integrated approach to market challenges. In addition, strategic collaborations have allowed companies to harness synergies that streamline manufacturing processes and lower production costs. As the market evolves, stakeholders are increasingly turning to agile models of product development, embracing digital transformation strategies that enable real-time data monitoring and predictive analytics. This rapid evolution reflects a broader trend in the life sciences sector where traditional boundaries are continuously redrawn, marking a transformative era characterized by unprecedented growth potentials and operational efficiencies.

Key Segmentation Insights for the Aptamers Market

A comprehensive analysis of market segmentation provides valuable insights into the diversified nature of the aptamers market. When considering the segmentation based on type, the market is examined across nucleic acid aptamers and peptide aptamers. Diving deeper, nucleic acid aptamers are further classified into DNA aptamers and RNA aptamers, highlighting a nuanced approach to target specificity and stability. The technological segmentation of the market is equally pivotal, with advanced methods such as Cell-SELEX Technology and LOPAC 1280 Technology driving innovation across various applications. Form-based segmentation distinguishes between liquid and solid-state formulations, offering distinct operational advantages and application-specific benefits in different environments. Moreover, the target-based segmentation underscores the market's breadth by studying cells, proteins, small molecules, and viruses; with cellular analyses further refined into cancerous cells and healthy cells to address varied research and clinical requirements. Application-based segmentation reveals a diverse utilization of aptamers across multiple fields, including biosensors, diagnostics, environmental monitoring, research and development, and therapeutics. This segment further subdivides biosensors into electrochemical and optical biosensors, the latter breaking down into fiber optic and fluorescence-based alternatives to cater to varying sensor performance criteria. Diagnostics have been refined into classifications such as blood diagnostics, enzyme-linked methods, and surface plasmon resonance techniques, whereas environmental monitoring is analyzed through the dual lenses of pollutant detection and water quality testing. Research and development segmentation highlights pivotal areas like biomarker discovery and protein interaction while the therapeutics segment is characterized by its focus on cancer treatment, cardiovascular diseases, and neurodegenerative diseases; with cancer treatment itself being analyzed by specific conditions such as breast cancer, colorectal cancer, and lung cancer. Finally, the segmentation based on the end-user encompasses academic and research institutions, biotechnology companies, hospitals and clinics, and pharmaceutical companies. This layered segmentation framework not only emphasizes the varied applications and technical nuances of aptamers but also illustrates the market's resilience and adaptability as it addresses evolving industry demands.

Based on Type, market is studied across Nucleic Acid Aptamers and Peptide Aptamers. The Nucleic Acid Aptamers is further studied across DNA Aptamers and RNA Aptamers.

Based on Technology, market is studied across Cell-SELEX Technology and LOPAC 1280 Technology.

Based on Form, market is studied across Liquid and Solid-State.

Based on Target, market is studied across Cells, Proteins, Small Molecules, and Viruses. The Cells is further studied across Cancerous Cells and Healthy Cells.

Based on Application, market is studied across Biosensors, Diagnostics, Environmental Monitoring, Research and Development, and Therapeutics. The Biosensors is further studied across Electrochemical Biosensors and Optical Biosensors. The Optical Biosensors is further studied across Fiber Optic and Fluorescence Based. The Diagnostics is further studied across Blood Diagnostics, Enzyme-Linked Methods, and Surface Plasmon Resonance. The Environmental Monitoring is further studied across Pollutant Detection and Water Quality Testing. The Research and Development is further studied across Biomarker Discovery and Protein Interaction. The Therapeutics is further studied across Cancer Treatment, Cardiovascular Diseases, and Neurodegenerative Diseases. The Cancer Treatment is further studied across Breast Cancer, Colorectal Cancer, and Lung Cancer.

Based on End-User, market is studied across Academic and Research Institutions, Biotechnology Companies, Hospital and Clinics, and Pharmaceutical Companies.

Key Regional Insights into the Aptamers Market

A regional perspective on the aptamers market reveals unique trends and growth dynamics across key geographies. In the Americas, the market is characterized by strong research facilities and robust funding channels, making it a hotbed for innovation and clinical applications. The region benefits from established regulatory frameworks and a growing network of biotechnology companies poised to leverage advancements in aptamer technologies for both diagnostics and therapeutics. Meanwhile, the Europe, Middle East & Africa region is witnessing steady growth driven by a combination of traditional research capabilities and new investments in translational science. The region's strategic positioning enables it to act as a bridge between cutting-edge research and practical, widespread adoption. In Asia-Pacific, rapid technological adoption, increased government support, and heightened investment in healthcare technologies are fueling market expansion. This region is rapidly emerging as an influential player, demonstrating significant improvements in research infrastructure and manufacturing capacity. These regional insights underscore how geographical factors, including regulatory standards, funding availability, and technological readiness, are orchestrating diverse pace and scale of industry growth worldwide.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Aptamers Market

The competitive landscape of the aptamers market is defined by a blend of established industry leaders and innovative startups. Renowned companies such as 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, and Aptamer Group are driving technological progress through robust research and development efforts. The market also features dynamic players like Aptamer Sciences, Inc., AptaTargets SL, and Aptus Biotech S.L., which play pivotal roles in expanding the application domains. Other influential entities, including ATDBio Ltd., Base Pair Biotechnologies, Inc., and Basking Biosciences, underscore the competitive intensity within the market. Cage Bio, Inc. and Creative Biogene contribute with innovative approaches to diagnostics and therapeutics, while organizations like Drive Therapeutics, LLC, Kaneka Corporation, and Maravai LifeSciences fortify the sector's technological backbone. Additionally, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, and Novartis AG are significant players who are at the forefront of leveraging aptamer-based solutions for specialized applications. Companies such as Qualigen, Inc., Raptamer Discovery Group, LLC, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc. further cement the market's position as an ecosystem driven by constant innovation and strategic market expansion initiatives. Their contributions reflect the industry's commitment to advancing methodologies and delivering high-quality solutions to end-users across various sectors.

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, LLC, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc.. Actionable Recommendations for Industry Leaders

Industry stakeholders should focus on fostering collaborative research initiatives and aligning with cutting-edge technological advancements to maintain a competitive edge in the aptamers market. It is advisable to invest in scaling up production capabilities and enhancing the quality control processes across different product forms to meet the increasing demand in both research and application domains. Diversification across segment-specific innovations, ranging from advanced cell-based selection techniques to the development of novel liquid and solid-state formats, will enhance market adaptability. Leveraging cross-sector partnerships can create synergies that expedite the regulatory approval process and drive market penetration, particularly in emerging regions. Proactive identification of potential value propositions and active monitoring of global market trends are essential strategies to safeguard investments and ensure sustainable growth. By embracing a forward-thinking approach and prioritizing customer-centric innovation, industry leaders can significantly influence market trajectories while delivering high-impact solutions tailored to evolving scientific and clinical needs.

Conclusion of the Aptamers Market Analysis

The convergence of innovative technologies, detailed segmentation strategies, and strategic regional growth has established a robust foundation for the aptamers market. This comprehensive analysis highlights not only the diverse applications and technical nuances but also the underlying drivers of market adoption worldwide. The synthesis of advanced research methodologies and ever-expanding collaborations reflects a vibrant landscape poised for future breakthroughs. As the market evolves, stakeholders are presented with opportunities to capitalize on technological innovations and drive operational efficiencies. The integrated approach to market segmentation and dynamics provides a solid framework for understanding current trends and anticipating future developments in the industry. In summary, the critical insights discussed offer valuable perspectives for decision-makers and business leaders aiming to navigate the competitive landscape and harness the transformative potential of aptamer-based applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases leading to elevated need for innovative diagnostic solutions
      • 5.1.1.2. Increasing demand for precise targeting and treatment in personalized medicine
      • 5.1.1.3. Expanding applications of aptamers in various sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High production costs and scalability issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced platforms and integration with nanotechnology
      • 5.1.3.2. Creating biosensor platforms utilizing aptamers for real-time monitoring of environmental pollutants
    • 5.1.4. Challenges
      • 5.1.4.1. Competition with existing and well-established technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increased adoption of RNA aptamers in therapeutic applications owing to their high specificity
    • 5.2.2. Application: Growing utilization of aptamers in therapeutics for treating various diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aptamers Market, by Type

  • 6.1. Introduction
  • 6.2. Nucleic Acid Aptamers
    • 6.2.1. DNA Aptamers
    • 6.2.2. RNA Aptamers
  • 6.3. Peptide Aptamers

7. Aptamers Market, by Technology

  • 7.1. Introduction
  • 7.2. Cell-SELEX Technology
  • 7.3. LOPAC 1280 Technology

8. Aptamers Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Solid-State

9. Aptamers Market, by Target

  • 9.1. Introduction
  • 9.2. Cells
    • 9.2.1. Cancerous Cells
    • 9.2.2. Healthy Cells
  • 9.3. Proteins
  • 9.4. Small Molecules
  • 9.5. Viruses

10. Aptamers Market, by Application

  • 10.1. Introduction
  • 10.2. Biosensors
    • 10.2.1. Electrochemical Biosensors
    • 10.2.2. Optical Biosensors
      • 10.2.2.1. Fiber Optic
      • 10.2.2.2. Fluorescence Based
  • 10.3. Diagnostics
    • 10.3.1. Blood Diagnostics
    • 10.3.2. Enzyme-Linked Methods
    • 10.3.3. Surface Plasmon Resonance
  • 10.4. Environmental Monitoring
    • 10.4.1. Pollutant Detection
    • 10.4.2. Water Quality Testing
  • 10.5. Research and Development
    • 10.5.1. Biomarker Discovery
    • 10.5.2. Protein Interaction
  • 10.6. Therapeutics
    • 10.6.1. Cancer Treatment
      • 10.6.1.1. Breast Cancer
      • 10.6.1.2. Colorectal Cancer
      • 10.6.1.3. Lung Cancer
    • 10.6.2. Cardiovascular Diseases
    • 10.6.3. Neurodegenerative Diseases

11. Aptamers Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic and Research Institutions
  • 11.3. Biotechnology Companies
  • 11.4. Hospital and Clinics
  • 11.5. Pharmaceutical Companies

12. Americas Aptamers Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Aptamers Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Aptamers Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. AstraZeneca and Aptamer Group collaborate to harness Optimer technology for advanced siRNA therapies
    • 15.3.2. Research collaboration on Xenoligo aptamers targets viral infectivity
    • 15.3.3. Zentek and McMaster announce positive results for the aptamer platform
    • 15.3.4. Astellas Pharma's strategic acquisition of IVERIC Bio enhances capabilities in retinal disease treatment
    • 15.3.5. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer's Disease Diagnostic Test
    • 15.3.6. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2bind GmbH
  • 2. Agilent Technologies, Inc.
  • 3. Aptagen, LLC
  • 4. Aptamer Group
  • 5. Aptamer Sciences, Inc.
  • 6. AptaTargets SL
  • 7. Aptus Biotech S.L.
  • 8. ATDBio Ltd.
  • 9. Base Pair Biotechnologies, Inc.
  • 10. Basking Biosciences
  • 11. Cage Bio, Inc.
  • 12. Creative Biogene
  • 13. Drive Therapeutics, LLC
  • 14. Kaneka Corporation
  • 15. Maravai LifeSciences
  • 16. Mediomics, LLC
  • 17. NeoVentures Biotechnology, Inc.
  • 18. NOVAPTECH
  • 19. Novartis AG
  • 20. Qualigen, Inc.
  • 21. Raptamer Discovery Group, LLC
  • 22. SomaLogic, Inc.
  • 23. TAGCyx Biotechnologies Inc.
  • 24. Vivonics, Inc.

LIST OF FIGURES

  • FIGURE 1. APTAMERS MARKET MULTI-CURRENCY
  • FIGURE 2. APTAMERS MARKET MULTI-LANGUAGE
  • FIGURE 3. APTAMERS MARKET RESEARCH PROCESS
  • FIGURE 4. APTAMERS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL APTAMERS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL APTAMERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL APTAMERS MARKET SIZE, BY TARGET, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL APTAMERS MARKET SIZE, BY TARGET, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. APTAMERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. APTAMERS MARKET DYNAMICS
  • TABLE 7. GLOBAL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL APTAMERS MARKET SIZE, BY DNA APTAMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL APTAMERS MARKET SIZE, BY RNA APTAMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL APTAMERS MARKET SIZE, BY PEPTIDE APTAMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL APTAMERS MARKET SIZE, BY CELL-SELEX TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL APTAMERS MARKET SIZE, BY LOPAC 1280 TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL APTAMERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL APTAMERS MARKET SIZE, BY SOLID-STATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL APTAMERS MARKET SIZE, BY CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL APTAMERS MARKET SIZE, BY CANCEROUS CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL APTAMERS MARKET SIZE, BY HEALTHY CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL APTAMERS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL APTAMERS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL APTAMERS MARKET SIZE, BY VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL APTAMERS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL APTAMERS MARKET SIZE, BY ELECTROCHEMICAL BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL APTAMERS MARKET SIZE, BY FIBER OPTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL APTAMERS MARKET SIZE, BY FLUORESCENCE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL APTAMERS MARKET SIZE, BY BLOOD DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL APTAMERS MARKET SIZE, BY ENZYME-LINKED METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL APTAMERS MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL APTAMERS MARKET SIZE, BY POLLUTANT DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL APTAMERS MARKET SIZE, BY WATER QUALITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL APTAMERS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL APTAMERS MARKET SIZE, BY PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL APTAMERS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL APTAMERS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL APTAMERS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL APTAMERS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL APTAMERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL APTAMERS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL APTAMERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL APTAMERS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL APTAMERS MARKET SIZE, BY HOSPITAL AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL APTAMERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 90. ARGENTINA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 91. ARGENTINA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 101. BRAZIL APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 102. BRAZIL APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 103. BRAZIL APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 104. BRAZIL APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 105. BRAZIL APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 106. BRAZIL APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CANADA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 116. CANADA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 117. CANADA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. CANADA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 119. CANADA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. CANADA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. CANADA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 129. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. MEXICO APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 131. MEXICO APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 132. MEXICO APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 133. MEXICO APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 134. MEXICO APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 135. MEXICO APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 136. MEXICO APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED STATES APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED STATES APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED STATES APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED STATES APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED STATES APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED STATES APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED STATES APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. AUSTRALIA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 176. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 178. AUSTRALIA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 180. AUSTRALIA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. AUSTRALIA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 187. CHINA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. CHINA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. CHINA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 190. CHINA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 191. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. CHINA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 193. CHINA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 194. CHINA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. INDIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 202. INDIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. INDIA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 204. INDIA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 205. INDIA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 206. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. INDIA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 208. INDIA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 209. INDIA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 210. INDIA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 211. INDIA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 212. INDIA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 213. INDIA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 214. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. INDONESIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. INDONESIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 217. INDONESIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. INDONESIA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 219. INDONESIA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 220. INDONESIA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 221. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. INDONESIA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 223. INDONESIA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 224. INDONESIA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. INDONESIA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 226. INDONESIA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 227. INDONESIA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 228. INDONESIA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 229. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. JAPAN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. JAPAN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 232. JAPAN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. JAPAN APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. JAPAN APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 235. JAPAN APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 236. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. JAPAN APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 238. JAPAN APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 239. JAPAN APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 240. JAPAN APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 241. JAPAN APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 242. JAPAN APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 243. JAPAN APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 244. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. MALAYSIA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. MALAYSIA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 247. MALAYSIA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. MALAYSIA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 249. MALAYSIA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 250. MALAYSIA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 251. MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. MALAYSIA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 253. MALAYSIA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 254. MALAYSIA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 255. MALAYSIA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 256. MALAYSIA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 257. MALAYSIA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 258. MALAYSIA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 259. MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. PHILIPPINES APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 262. PHILIPPINES APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 264. PHILIPPINES APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 266. PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 268. PHILIPPINES APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 270. PHILIPPINES APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 272. PHILIPPINES APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 274. PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. SINGAPORE APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. SINGAPORE APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 277. SINGAPORE APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. SINGAPORE APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 279. SINGAPORE APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 280. SINGAPORE APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 281. SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. SINGAPORE APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 283. SINGAPORE APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 284. SINGAPORE APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 285. SINGAPORE APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 286. SINGAPORE APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 287. SINGAPORE APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 288. SINGAPORE APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 289. SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH KOREA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH KOREA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH KOREA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 296. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 298. SOUTH KOREA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 300. SOUTH KOREA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 302. SOUTH KOREA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 304. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. TAIWAN APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. TAIWAN APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 307. TAIWAN APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. TAIWAN APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 309. TAIWAN APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 310. TAIWAN APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 311. TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. TAIWAN APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 313. TAIWAN APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 314. TAIWAN APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 315. TAIWAN APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 316. TAIWAN APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 317. TAIWAN APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 318. TAIWAN APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 319. TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 320. THAILAND APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. THAILAND APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 322. THAILAND APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. THAILAND APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 324. THAILAND APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 325. THAILAND APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 326. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. THAILAND APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 328. THAILAND APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 329. THAILAND APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 330. THAILAND APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 331. THAILAND APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 332. THAILAND APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 333. THAILAND APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 334. THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 335. VIETNAM APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. VIETNAM APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 337. VIETNAM APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 338. VIETNAM APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 339. VIETNAM APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 340. VIETNAM APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 341. VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 342. VIETNAM APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 343. VIETNAM APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 344. VIETNAM APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 345. VIETNAM APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 346. VIETNAM APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 347. VIETNAM APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 348. VIETNAM APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 349. VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 355. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 356. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 357. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 358. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 359. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 360. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 361. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 362. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 363. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 364. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 365. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 366. DENMARK APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 367. DENMARK APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 368. DENMARK APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 369. DENMARK APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 370. DENMARK APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 371. DENMARK APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 372. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 373. DENMARK APTAMERS MARKET SIZE, BY BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 374. DENMARK APTAMERS MARKET SIZE, BY OPTICAL BIOSENSORS, 2018-2030 (USD MILLION)
  • TABLE 375. DENMARK APTAMERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 376. DENMARK APTAMERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
  • TABLE 377. DENMARK APTAMERS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 378. DENMARK APTAMERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 379. DENMARK APTAMERS MARKET SIZE, BY CANCER TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 380. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 381. EGYPT APTAMERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 382. EGYPT APTAMERS MARKET SIZE, BY NUCLEIC ACID APTAMERS, 2018-2030 (USD MILLION)
  • TABLE 383. EGYPT APTAMERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 384. EGYPT APTAMERS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 385. EGYPT APTAMERS MARKET SIZE, BY TARGET, 2018-2030 (USD MILLION)
  • TABLE 386. EGYPT APTAMERS MARKET SIZE, BY CELLS, 2018-2030 (USD MILLION)
  • TABLE 387. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE